The European Commission, acting with and on behalf of the Member States through the Health Emergency Response and Preparedness Authority (HERA), and vaccine developers BioNTech-Pfizer, reached on Friday 26 May, an agreement to better respond to Member States’ estimates of the evolving need for Covid-19 vaccines.
The amendment to the vaccine supply contract takes account of the improved epidemiological situation, while continuing to guarantee access to the very latest version of the...